Fostamatinib, a Syk-Kinase Inhibitor, Does Not Affect Methotrexate Pharmacokinetics in Patients With Rheumatoid Arthritis Muhammad Baluom, Emil Samara,et al. J Clin Pharmacol 2010;
The Syk inhibitor fostamatinib disodium (R788) inhibits tumor growth in the Eµ - TCL1 transgenic mouse model of CLL by blocking antigen-dependent B-cell receptor signaling Mirza Suljagic, Pablo G. Longo,et al. Blood 2010;116: 4894-4905
The pharmacological and toxicological properties of this product have not been fully investigated. Exercise caution in use and handling. This product must not be used in humans.